Adaptive Biotechnologies (ADPT) Free Cash Flow (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Free Cash Flow of -$10.3 million for Q1 2026, down 4278.39% sequentially from -$236000.0 in Q4 2025, and up 63.99% YoY from -$6.3 million in Q1 2025.
Adaptive Biotechnologies (ADPT) Free Cash Flow (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Free Cash Flow data on file, last reported at -$10.3 million in Q1 2026.
- Quarterly Free Cash Flow rose 63.99% year-over-year to -$10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.6 million (up 65.29% YoY) and the FY2025 annual result came in at -$48.9 million, up 50.5% from the prior year.
- Free Cash Flow eased to -$10.3 million in Q1 2026 per ADPT's latest filing, from -$236000.0 in the prior quarter.
- The five-year high for Free Cash Flow was -$236000.0 in Q4 2025, with the low at -$67.5 million in Q1 2022.
- Average Free Cash Flow over 5 years is -$29.5 million, with a median of -$28.5 million recorded in 2023.
- Year-over-year, Free Cash Flow sank 204.81% in 2022 and surged 98.12% in 2025.
- Adaptive Biotechnologies' Free Cash Flow stood at -$29.1 million in 2022, then advanced by 9.64% to -$26.3 million in 2023, then surged by 52.22% to -$12.6 million in 2024, then surged by 98.12% to -$236000.0 in 2025, then slumped by 4278.39% to -$10.3 million in 2026.
- Business Quant data shows ADPT's Free Cash Flow at -$10.3 million in Q1 2026, -$236000.0 in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -42.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 816.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.09 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 257.97 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 18.03 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 201.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 491.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 122.38 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -10.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.33 Mn |
| Mar 31, 2026 | -10.33 Mn |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Sep 30, 2025 | -7.57 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Mar 31, 2025 | -28.70 Mn |
| Mar 31, 2025 | -28.70 Mn |
| Dec 31, 2024 | -12.57 Mn |
| Dec 31, 2024 | -12.57 Mn |
| Sep 30, 2024 | -27.41 Mn |
| Sep 30, 2024 | -27.41 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Mar 31, 2024 | -39.47 Mn |
| Mar 31, 2024 | -39.47 Mn |
| Dec 31, 2023 | -26.31 Mn |
| Dec 31, 2023 | -26.31 Mn |